By PTI BHOPAL: Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January...
Bharat Biotech
By PTI HYDERABAD: Bharat Biotech has requested the central government to include its intranasal covid-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients...
By PTI HYDERABAD: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year...
By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials and booster doses for...
By Express News Service NEW DELHI: A booster dose of Covaxin enhances vaccine effectiveness against the Delta variant and gives protection against Omicron variants...
By PTI NEW DELHI: Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approval in children 6-12...
Express News Service NEW DELHI: The US Food and Drug Administration (FDA) has put on hold the phase 2/3 clinical trials of Bharat Biotech’s...
By PTI NEW DELHI: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of...
By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and...

Express News Service NEW DELHI: A third booster dose of Covaxin, the Covid19 vaccine by Bharat Biotech, is safe and immunogenic and may be...